Correction
Corrigendum: Gardasil® as adjunctive therapy for respiratory papillomatosis at Red Cross Children’s Hospital, Cape Town
Journal of the Colleges of Medicine of South Africa | Vol 2, No 1 | a93 |
DOI: https://doi.org/10.4102/jcmsa.v2i1.93
| © 2024 Shavina Frank, Jessica K. McGuire, Fiona Kabagenyi, Vincent Pretorius, Shazia Peer
| This work is licensed under CC Attribution 4.0
Submitted: 29 May 2024 | Published: 18 July 2024
Submitted: 29 May 2024 | Published: 18 July 2024
About the author(s)
Shavina Frank, Division of Otorhinolaryngology, Department of Surgery, Faculty of Health Sciences, University of Cape Town (Red Cross War Memorial Children’s Hospital), Cape Town, South AfricaJessica K. McGuire, Division of Otorhinolaryngology, Department of Surgery, Faculty of Health Sciences, University of Cape Town (Red Cross War Memorial Children’s Hospital), Cape Town, South Africa
Fiona Kabagenyi, Department of Ear Nose and Throat, Faculty of Medicine, Makerere University, Kampala, Uganda
Vincent Pretorius, Division of Otorhinolaryngology, Department of Surgery, Faculty of Health Sciences, University of Cape Town (Red Cross War Memorial Children’s Hospital), Cape Town, South Africa
Shazia Peer, Division of Otorhinolaryngology, Department of Surgery, Faculty of Health Sciences, University of Cape Town (Red Cross War Memorial Children’s Hospital), Cape Town, South Africa
Abstract
No abstract available.
Keywords
Gardasil-4; Gardasil-4®; juvenile-onset recurrent respiratory papilloma; vaccine; upper airway obstruction; tracheostomy; Derkay-Coltrera score; human papilloma virus
Metrics
Total abstract views: 301Total article views: 252